LERCANIDIPINE ALMUS 10 mg, film-coated tablet 30 tablets
Active ingredients: Lercanidipine hydrochloride, Lercanidipine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LERCANIDIPINE ALMUS 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes aluminium PVC PVDC de 30 comprimés
- Marketing authorisation holder
- ALMUS FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67241371CIP73026019CIP133400930260197Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LERCANIDIPINEcomprimé | 10 mg · un comprimé | SA |
| LERCANIDIPINEcomprimé | 9,4 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.